Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant MenC-TT and PCV7 booster study in PCV7-primed toddlers
2007-004276-39Phase 3Completed
- Sponsor
- Baxter International Inc.
- Start
- Oct 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in meningococcal disease and pneumococcal disease comparing Concomitant MenC-TT + PCV7, PCV7 alone and MenC-TT alone (3 arms). Primary endpoint: Immunogenicity. Started Oct 2007; status: completed.
02
Drugs
meningococcal group C conjugate vaccinepneumococcal 7-valent conjugate vaccine
03
Conditions
meningococcal diseasepneumococcal disease
Beyond the preview
Go deeper on 2007-004276-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004276-39.